Sclerosing Epithelioid Fibrosarcoma — Variants & evidence

Sclerosing Epithelioid Fibrosarcoma — Variants & evidence · CancerIndex

Variants & evidence

Curated clinical evidence by variant and therapy

3 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.

civicCuratedShowing 1–3 of 3 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.

Therapy	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
CREB3L1 Fusion3
(diagnostic)	Diagnostic	B	Supports Positive	3	accepted	EID12058 In this 2017 study, the authors utilized SNP arrays, expression profiling, transcriptome, and whole-exome sequencing to further characterize sclerosing epithelioid fibrosarcoma (SEF) and low-grade fi… (full text at CIViC) PMID 28939748 · Arbajian et al., 2017 · Open in CIViC	civic
〃	Diagnostic	C	Supports Positive	3	accepted	EID12057 In this 2014 study, the authors compared 10 primary sclerosing epithelioid fibrosarcomas (SEF), 4 cases of low-grade fibromyxoid sarcoma (LGFMS), and one primary hybrid SEF/LGFMS. Patients with SEF ra… (full text at CIViC) PMID 24441665 · Arbajian et al., 2014 · Open in CIViC	civic
〃	Diagnostic	C	Supports Positive	3	accepted	EID12059 In this 2015 study, the authors aimed to further characterize the molecular characteristics of pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma (LGFMS) lesio… (full text at CIViC) PMID 25231134 · Prieto-Granada et al., 2015 · Open in CIViC	civic

Data updated 23 hours agoSource updated unknownsource: civic (CC0)

Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.